Table 1. – Clinical characteristics of patients with Chronic Coronary Syndrome (CCS), Acute Coronary Syndrome (ACS), and Control Group.
| Characterístics | CCS (N = 100) | ACS (N = 70) | Control (N = 64) |
|---|---|---|---|
| Age (years) | 63.32 ± 9.8 | 63.4 ± 11.9 | 58.97± 11.2 |
| Sex (male/female) | 59/41 | 49/21 | 40/24 |
| Risk factors | |||
| Hypertension, n (%) | 78 (78%) | 55 (78.57%) | 36 (56.25%) |
| Diabetes, n (%) | 43 (43%) | 31 (44.28%) | - |
| Dyslipidemia, n (%) | 30 (30%) | 23 (33.85%) | 17 (26.56%) |
| Cardiovascular disease, n (%) | 12 (12%) | 6 (8.57%) | - |
| Stroke, n (%) | 6 (6%) | 3 (4.28%) | - |
| Revascularization, n (%) | 12 (12%) | 6 (8.57%) | - |
| *AMI, n (%) | - | 29 (41.42%) | - |
| Stent, n (%) | 18 (18%) | 14 (20%) | - |
| Smoking, n (%) | 39 (39%) | 31 (44.28%) | 5 (7.81%) |
| Medications | |||
| Beta blocker, n (%) | 52 (52%) | 36 (51.42%) | 6 (9.38%) |
| BCC, n (%) | 11 (11%) | 8 (11.42%) | 7 (10.94%) |
| ACEI/BRA, n (%) | 38 (38%) | 23 (32.85%) | 9 (14.06%) |
| ARA, n (%) | 26 (26%) | 10 (14.28%) | 19 (29.69%) |
| Diuretic, n (%) | 21 (21%) | 11 (15.71%) | 14 (21.86%) |
| Antidiabetic, n (%) | 22 (22%) | 15 (21.42%) | |
| Statin, n (%) | 60 (60%) | 32 (45.71%) | - |
| Insulin, n (%) | 3 (3%) | 3 (4.28%) | 8 (12.5%) |
| Nitrates, n (%) | 15 (15%) | 4 (5.71%) | - |
| Antiplatelet agent, n (%) | 67 (67%) | 35 (50%) | - |
| Fibrates, n (%) | 3 (3%) | 1 (1.42%) | - |
| Anti-ischemic, n (%) | 5 (5%) | - | - |
*AMI: acute myocardial infarction - [AMI was the reason for hospitalization]. †BCC: Blocker Calcium Channels; ACEI/BRA: angiotensin-converting enzyme; ARA: angiotensin receptor antagonist.